Figure 2.

A representative figure of the potential of iPSCs obtained from a patient or a healthy adult is shown. The neural cells obtained from patients can be corrected by gene editing to obtain healthy neural cells, which can be used as an isogenic control in modelling this disease. Healthy neural cells obtained from a healthy adult can undergo gene editing, and neural cells harbouring a mutation from a neurodegenerative disease can be obtained for disease modelling.